Estimation of Galanin hormone levels and additional biochemical markers in polycystic ovary syndrome patients

Abstract

Polycystic ovarian syndrome (PCOS), which is typified by irregular menstrual cycles, hyperandrogens, and polycystic ovaries, is the most prevalent endocrine and metabolic disorder affecting premenopausal women. Women with PCOS are more likely to develop metabolic syndrome because they are at a higher risk of acquiring hypertension and dyslipidemia. Twenty health screen examinees who were admitted to the Tikrit Teaching Hospital's primary accommodations between January and March 2024 were referred to our organization. Forty patients were selected on the basis of their history of Polycystic Ovarian Syndrome, blood test results, abdominal ultrasound results, and whether or not they provided written informed consent. For those who have Polycystic Ovary Syndrome, blood galanin levels were significantly elevated, independent of age or the results of laboratory tests (144.9±9.2vs. 30.18±6.6, p